Kane Biotech ( (TSE:KNE) ) just unveiled an update. Kane Biotech recently presented promising clinical and pre-clinical data for its revyve Antimicrobial Wound Gel and Gel Spray at major U.S. medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback